Anti-Cancer Drugs · 2007 · 41 citations · 11 references
MedicineHematologyOncologyCancer ImmunologyChemotherapyMedical OncologyAdverse Effects Of ChemotherapyAnemiaChemotherapy In Hematologic MalignanciesHematologic MalignanciesHematologic ToxicityMalignant NeoplasmsDrug-induced Hemolytic AnemiaDrug-induced Immune HemolysisHemolytic ToxicityImmune-mediated Hemolytic AnemiaOxaliplatin-based Therapy
We report a 59-year-old woman diagnosed with metastasic colorectal cancer who developed immune hemolytic anemia during FOLFOX chemotherapy (oxaliplatin/leucovorin/5-fluorouracil). Immunohematologic studies demonstrated that immune hemolysis was oxaliplatin-mediated. On the basis of this case and in a review of the literature in which 13 cases of previously reported oxaliplatin-induced immune cytopenia have been identified, we suggest some clinical clues regarding the use of oxaliplatin in cancer patients.
11
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
Thierry André, C. Boni, Lamia Mounedji-Boudiaf et al. · New England Journal of Medicine · 2004 · 3.7K citations · Full text
Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin
Brian R. Curtis, J Kaliszewski, Marisa B. Marques et al. · American Journal of Hematology · 2006 · 125 citations · Full text
Medicine, Hematology, Oncology +17
E. P. Getaz, Sunmolu Beckley, John W. Fitzpatrick et al. · New England Journal of Medicine · 1980 · 86 citations
Medicine, Oncology, Pharmacology +17
Oxaliplatin‐induced immune pancytopenia
Behrouz Mansouri Taleghani, Stefano Fontana, Oliver Meyer et al. · Transfusion · 2005 · 65 citations
Medicine, Hematology, Oncology +15